FDA News Digest
November 5, 2007
______________________________________
NOTE TO SUBSCRIBERS
We want to let you know that you will soon
start receiving
IN
THIS WEEK'S ISSUE
»
News
-- FDA Probe Shows That Consumers Continue to Buy Risky Drugs Online
-- Manufacturer Agrees to Suspend Marketing of Bleeding-Control Drug Trasylol
-- More Than $300,000 in Drugs, Supplements Seized From St. Louis Company
-- FDA Requests Recall of Illegal 'True Man' and 'Energy Max' Drug Products
» Upcoming
Public Meetings
» Consumer Health Information
To access the RSS feed of FDA news releases, go
to http://www.fda.gov/bbs/topics/news/rssPress.xml.
[What
is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.] ___________________________________________ CONGRESSIONAL
TESTIMONY Nov. 1 -- FDA Commissioner Andrew C. von Eschenbach,
M.D., appeared before the House Subcommittee on Oversight and
Investigations. Subject: FDA's foreign drug inspection
program http://www.fda.gov/ola/2007/foreigndrugs110107.html To view an archive of past testimony by FDA officials, go to
http://www.fda.gov/ola/listing.html
_________________________________________________
SAFETY
ALERTS/RECALLS